Altre lingue Anika Therapeutics, Inc.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 11/06/2024			Variaz. 5gg	Var. 1 gen.
25,86 ^USD	+0,58%		-2,01%	+14,12%

28/05	Anika Therapeutics approva un programma di riacquisto di azioni di 40 milioni di dollari	MT
28/05	Anika Therapeutics, Inc. (NasdaqGS:ANIK) annuncia un riacquisto di azioni per un valore di 40 milioni di dollari.	CI

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	07/06
Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics	30/05
Anika Therapeutics Approves $40 Million Share Repurchase Program	28/05
Anika Therapeutics, Inc. announces an Equity Buyback for $40 million worth of its shares.	28/05
Anika Enters into Cooperation Agreement with Caligan Partners	28/05
Anika Therapeutics, Inc. Announces Board Changes	28/05
Anika Therapeutics, Inc. authorizes a Buyback Plan.	28/05
Anika: Q1 Earnings Snapshot	08/05
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09	08/05
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 Revenue $40.5M, vs. Street Est of $39.1M	08/05
Anika Therapeutics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	08/05
Anika Announces CFO Transition	08/05
Anika Reports First Quarter 2024 Financial Results	08/05
Anika Therapeutics, Inc. Announces Management Changes, Effective June 3, 2024	08/05
Anika Therapeutics, Inc. Announces CFO Changes	08/05
Anika Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Anika Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	06/05
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03/05
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024	18/04
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference	02/04

Non ci sono risultati per questa ricerca